COVID-19 a reminder of the challenge of emerging infectious diseases

Newswise — WHAT: The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC). Their commentary appears in The New England Journal of Medicine.

NIAID Director Anthony S. Fauci, M.D., NIAID Deputy Director for Clinical Research and Special Projects H. Clifford Lane, M.D., and CDC Director Robert R. Redfield, M.D., shared their observations in the context of a recently published report on the early transmission dynamics of COVID-19. The report provided detailed clinical and epidemiological information about the first 425 cases to arise in Wuhan, Hubei Province, China.

In response to the outbreak, the United States and other countries instituted temporary travel restrictions, which may have slowed the spread of COVID-19 somewhat, the authors note. However, given the apparent efficiency of virus transmission, everyone should be prepared for COVID-19 to gain a foothold throughout the world, including in the United States, they add. If the disease begins to spread in U.S. communities, containment may no longer be a realistic goal and response efforts likely will need to transition to various mitigation strategies, which could include isolating ill people at home, closing schools and encouraging telework, the officials write.

Drs. Fauci, Lane and Redfield point to the many research efforts now underway to address COVID-19. These include numerous vaccine candidates proceeding toward early-stage clinical trials as well as clinical trials already underway to test candidate therapeutics, including an NIAID-sponsored trial of the experimental antiviral drug remdesivir that began enrolling participants on February 21, 2020.

"The COVID-19 outbreak is a stark reminder of the ongoing challenge of emerging and re-emerging infectious pathogens and the need for constant surveillance, prompt diagnosis and robust research to understand the basic biology of new organisms and our susceptibilities to them, as well as to develop effective countermeasures," the authors conclude.

###

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 1929
Released: 26-May-2020 7:30 PM EDT
Dementia gene raises risk of severe COVID-19
University of Exeter

Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.

Released: 26-May-2020 4:00 PM EDT
#FitForTheFrontLine Challenge Unites Nation’s Top Medical Centers in Support of Front-Line Health Care Workers
Mount Sinai Health System

Fitness challenge honors and supports health care heroes at Mount Sinai Health System and Academic Centers Across the Country. Goldman Sachs & Co., Peloton, Discovery, NBCUniversal Owned Television Stations, dtx and Pinterest Support First-Ever Collective Medical Center Campaign.

Newswise: 232760_web.jpg
Released: 26-May-2020 3:15 PM EDT
Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in The New England Journal of Medicine.

Released: 26-May-2020 3:10 PM EDT
High Rates of COVID-19 on American Indian Reservations – Water and Language Barriers Affect Risk
Wolters Kluwer Health: Lippincott Williams and Wilkins

Early in the pandemic, American Indian Reservations have experienced a disproportionately high incidence of COVID-19 infections: four times higher than in the US population, reports a study in the July/August issue of the Journal of Public Health Management and Practice. The special issue of JPHMP focuses on COVID-19, with commentaries and scientific articles describing the pandemic in the United States and globally. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise:Video Embedded covid-19-a-wake-up-call-for-the-need-for-new-antiviral-weapons
VIDEO
Released: 26-May-2020 3:00 PM EDT
COVID-19: A wake-up call for the need for new antiviral weapons
Morgridge Institute for Research

Even after heroic medical and societal efforts finally break the back of the current COVID-19 pandemic, the global sigh of relief may not last long. The chilling reality is that viral threats are growing more common. And they’re getting deadlier.

Newswise: Experts available to comment on racial and social inequality in COVID-19 health care
Released: 26-May-2020 12:55 PM EDT
Experts available to comment on racial and social inequality in COVID-19 health care
Indiana University

As all 50 U.S. states ease economic restrictions implemented in response to the coronavirus, health and policy experts are braced for a potential second wave of COVID-19. Based on the first phase of the crisis, the hardest-hit populations are anticipated among communities of color, which have been disproportionally affected. According to a recent report from American Public Media Research Lab, African Americans are more than twice as likely to die from COVID-19 as Latino or Asian Americans, and nearly 2 1/2 times as likely as whites. Indiana University experts on racial inequality, social inequality in health care and demographics data are available to comment on these topics.

26-May-2020 12:15 PM EDT
UCLA receives $1 million for COVID-19 Rapid Response Initiative
UCLA Fielding School of Public Health

A $1 million gift from the Shurl and Kay Curci Foundation will support the UCLA COVID-19 Rapid Response Initiative, a partnership of the UCLA Fielding School of Public Health and the David Geffen School of Medicine at UCLA.


Showing results

110 of 1929

close
1.41514